Podcast

Remaining Challenges in the Treatment of HER2-Positive Breast Cancer

Author(s):

OncLive Staff

In the first segment, Dr Mahtani and colleagues outline challenges and remaining unmet needs in the management of patients with HER2-positive breast cancer.

Related Videos
Vered Stearns, MD
Kevin Kalinsky, MD, MS
Peter Schmid, MD, PhD, FRCP, discusses updated KEYNOTE-522 data showing that pembrolizumab plus chemotherapy improves EFS in early-stage TNBC.
David Rimm, MD, PhD
Vered Stearns, MD
Ruth M. O’Regan, MD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Sheldon M. Feldman, MD
Dana Zakalik, MD
Alberto Montero, MD, MBA, CPHQ
Related Content
Felipe Batalini, MD, of Mayo Clinic College of Medicine
December 6th 2024

Targeting PIK3CA With Allosteric Inhibitors Is Promising New Approach in Breast Cancer

Binod Dhakal, MD, associate professor, medicine, Division of Hematology, Medical College of Wisconsin; Muhamed Baljevic, MD, associate professor, medicine, Division of Hematology Oncology, director, Plasma Cell Disorders Research, director, Vanderbilt Amyloidosis Multidisciplinary Program, co-chair, Protocol Review and Monitoring System, disease team lead, plasma cell dyscrasias and lymphomas, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
December 6th 2024

How to Optimize Patient Selection for Multiple Myeloma Therapies: With Binod Dhakal, MD; and Muhamed Baljevic, MD

November Recap
December 2nd 2024

Revisit Every OncLive On Air Episode From November 2024

John Strickler, MD, professor, medicine, Division of Medical Oncology, associate director, Clinical Research – GI Oncology, co-leader, Precision Cancer Medicine and Investigational Therapeutics Program, Duke Cancer Institute
December 2nd 2024

Pancreatic Cancer Research Surfaces Treatment Developments and Challenges: With John Strickler, MD

Breast Cancer
November 27th 2024

Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC

The OncFive: Top Oncology Articles for the Week of 11/17
November 23rd 2024

The OncFive: Top Oncology Articles for the Week of 11/17